Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America
With the completion of the North America integration, the existing commercialised portfolio of biosimilars, Ogiviri…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Fulphila
Biocon and Mylan launch fulphila — biosimilar to pegfilgrastim, in Canada
The approval of fulphila was based on a comprehensive package of analytical, non-clinical and clinical data, which confirmed that…
Biocon and Mylan Launch Fulphila, Biosimilar Pegfilgrastim, in Australia
The approval of Fulphila was based on a comprehensive package of analytical, nonclinical and clinical data, which confirmed that…
USFDA approves Biocon’s sBLA for Pegfilgrastim new manufacturing facility
Expanded capacity will enable greater patient access globally